Delivery Order SPE2DB24D2013-SPE2DB25FCGTZ
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,031.57 firm fixed-price delivery order contract has a completion date of December 9, 2024. This award is part of AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $4,991.94 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024, with a completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The $25,069.68 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024. This award is a child under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,115.88 firm fixed-price delivery order is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,413.92 delivery order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,428.36 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,751.31 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 12, 2024 with an ultimate completion date of November 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,361.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024, with an ultimate completion date of November 29, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,632.54. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order and is priced on a firm fixed price basis. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This contract award is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,918.21 firm-fixed price delivery order has an ultimate completion date of August 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various...